Régions déterminant la complémentarité : Questions médicales fréquentes
Nom anglais: Complementarity Determining Regions
Descriptor UI:D022801
Tree Number:G02.111.570.060.425.160
Termes MeSH sélectionnés :
Network Meta-Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Régions déterminant la complémentarité : Questions médicales les plus fréquentes",
"headline": "Régions déterminant la complémentarité : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Régions déterminant la complémentarité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Régions déterminant la complémentarité"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Région variable d'immunoglobuline",
"url": "https://questionsmedicales.fr/mesh/D007135",
"about": {
"@type": "MedicalCondition",
"name": "Région variable d'immunoglobuline",
"code": {
"@type": "MedicalCode",
"code": "D007135",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.060.425"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Régions déterminant la complémentarité",
"alternateName": "Complementarity Determining Regions",
"code": {
"@type": "MedicalCode",
"code": "D022801",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Boris I Chobrutskiy",
"url": "https://questionsmedicales.fr/author/Boris%20I%20Chobrutskiy",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, Oregon, USA."
}
},
{
"@type": "Person",
"name": "George Blanck",
"url": "https://questionsmedicales.fr/author/George%20Blanck",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA."
}
},
{
"@type": "Person",
"name": "Elena S Klimtchuk",
"url": "https://questionsmedicales.fr/author/Elena%20S%20Klimtchuk",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Daniele Peterle",
"url": "https://questionsmedicales.fr/author/Daniele%20Peterle",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Lawreen H Connors",
"url": "https://questionsmedicales.fr/author/Lawreen%20H%20Connors",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Kenward-Roger-type corrections for inference methods of network meta-analysis and meta-regression.",
"datePublished": "2023-07-03",
"url": "https://questionsmedicales.fr/article/37399845",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jrsm.1652"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.",
"datePublished": "2024-09-18",
"url": "https://questionsmedicales.fr/article/39293856",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1183/16000617.0046-2024"
}
},
{
"@type": "ScholarlyArticle",
"name": "Topical anti-inflammatory treatments for eczema: network meta-analysis.",
"datePublished": "2024-08-06",
"url": "https://questionsmedicales.fr/article/39105474",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD015064.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.",
"datePublished": "2023-08-31",
"url": "https://questionsmedicales.fr/article/37650547",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD013730.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.",
"datePublished": "2022-09-02",
"url": "https://questionsmedicales.fr/article/36691161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-063884"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes chimiques",
"item": "https://questionsmedicales.fr/mesh/D055598"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes biochimiques",
"item": "https://questionsmedicales.fr/mesh/D001669"
},
{
"@type": "ListItem",
"position": 4,
"name": "Région variable d'immunoglobuline",
"item": "https://questionsmedicales.fr/mesh/D007135"
},
{
"@type": "ListItem",
"position": 5,
"name": "Régions déterminant la complémentarité",
"item": "https://questionsmedicales.fr/mesh/D022801"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Régions déterminant la complémentarité - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Régions déterminant la complémentarité",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Régions déterminant la complémentarité",
"description": "Comment identifier les CDR dans un anticorps ?\nQuels tests révèlent la présence de CDR ?\nLes CDR peuvent-ils être visualisés ?\nQuel rôle joue la bioinformatique dans l'étude des CDR ?\nLes CDR sont-ils spécifiques à chaque anticorps ?",
"url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Network+Meta-Analysis&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Régions déterminant la complémentarité",
"description": "Quels symptômes indiquent une réponse immunitaire anormale ?\nLes CDR affectent-ils les symptômes d'infections ?\nComment les CDR influencent-ils les maladies allergiques ?\nLes CDR sont-ils liés à des symptômes de maladies auto-immunes ?\nPeut-on prédire des symptômes grâce aux CDR ?",
"url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Network+Meta-Analysis&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Régions déterminant la complémentarité",
"description": "Comment prévenir les maladies liées aux CDR ?\nLes CDR peuvent-ils être ciblés pour la prévention ?\nQuel rôle joue l'alimentation dans la prévention des maladies liées aux CDR ?\nLes tests génétiques aident-ils à prévenir les maladies liées aux CDR ?\nComment le mode de vie influence-t-il la prévention des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Network+Meta-Analysis&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Régions déterminant la complémentarité",
"description": "Comment les CDR sont-ils utilisés en thérapie ?\nLes traitements ciblant les CDR sont-ils efficaces ?\nQuels types de médicaments ciblent les CDR ?\nLes CDR peuvent-ils être modifiés pour améliorer les traitements ?\nQuels sont les effets secondaires des traitements ciblant les CDR ?",
"url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Network+Meta-Analysis&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Régions déterminant la complémentarité",
"description": "Quelles complications peuvent survenir avec des CDR défectueux ?\nLes CDR sont-ils impliqués dans des complications infectieuses ?\nComment les CDR affectent-ils les traitements anticancéreux ?\nLes complications liées aux CDR peuvent-elles être traitées ?\nQuels sont les risques de complications lors de thérapies ciblant les CDR ?",
"url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Network+Meta-Analysis&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Régions déterminant la complémentarité",
"description": "Quels facteurs augmentent le risque de maladies liées aux CDR ?\nL'âge influence-t-il le risque lié aux CDR ?\nLe stress a-t-il un impact sur les CDR ?\nLes infections antérieures influencent-elles les CDR ?\nComment le mode de vie affecte-t-il les CDR ?",
"url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Network+Meta-Analysis&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les CDR dans un anticorps ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les CDR sont identifiés par séquençage et analyse des structures d'anticorps."
}
},
{
"@type": "Question",
"name": "Quels tests révèlent la présence de CDR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'affinité et de liaison aux antigènes sont utilisés pour détecter les CDR."
}
},
{
"@type": "Question",
"name": "Les CDR peuvent-ils être visualisés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, par des techniques comme la cristallographie aux rayons X ou la RMN."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la bioinformatique dans l'étude des CDR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La bioinformatique aide à prédire et modéliser les CDR à partir de séquences d'anticorps."
}
},
{
"@type": "Question",
"name": "Les CDR sont-ils spécifiques à chaque anticorps ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque anticorps a des CDR uniques qui déterminent sa spécificité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réponse immunitaire anormale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des allergies ou des maladies auto-immunes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les CDR affectent-ils les symptômes d'infections ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des CDR efficaces peuvent réduire la gravité des symptômes d'infections."
}
},
{
"@type": "Question",
"name": "Comment les CDR influencent-ils les maladies allergiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des CDR spécifiques peuvent reconnaître des allergènes, entraînant des réactions."
}
},
{
"@type": "Question",
"name": "Les CDR sont-ils liés à des symptômes de maladies auto-immunes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des CDR mal régulés peuvent cibler des tissus sains, provoquant des symptômes."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes grâce aux CDR ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études sur les CDR peuvent aider à prédire la réponse immunitaire et les symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux CDR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'éducation sur les allergies peuvent aider à prévenir ces maladies."
}
},
{
"@type": "Question",
"name": "Les CDR peuvent-ils être ciblés pour la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des stratégies de vaccination ciblant les CDR peuvent prévenir certaines infections."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention des maladies liées aux CDR ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut renforcer le système immunitaire et prévenir les maladies."
}
},
{
"@type": "Question",
"name": "Les tests génétiques aident-ils à prévenir les maladies liées aux CDR ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les risques et guider la prévention."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la prévention des maladies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant exercice et gestion du stress, aide à prévenir les maladies."
}
},
{
"@type": "Question",
"name": "Comment les CDR sont-ils utilisés en thérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les CDR sont ciblés pour développer des anticorps thérapeutiques contre des maladies."
}
},
{
"@type": "Question",
"name": "Les traitements ciblant les CDR sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils montrent une efficacité dans le traitement de diverses maladies, y compris le cancer."
}
},
{
"@type": "Question",
"name": "Quels types de médicaments ciblent les CDR ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticorps monoclonaux et des inhibiteurs de points de contrôle immunitaire ciblent les CDR."
}
},
{
"@type": "Question",
"name": "Les CDR peuvent-ils être modifiés pour améliorer les traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la modification des CDR peut augmenter l'affinité et la spécificité des anticorps."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ciblant les CDR ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions immunitaires indésirables et des allergies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des CDR défectueux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des CDR défectueux peuvent entraîner des maladies auto-immunes et des allergies."
}
},
{
"@type": "Question",
"name": "Les CDR sont-ils impliqués dans des complications infectieuses ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des CDR inefficaces peuvent aggraver les infections et retarder la guérison."
}
},
{
"@type": "Question",
"name": "Comment les CDR affectent-ils les traitements anticancéreux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des CDR mal ciblés peuvent réduire l'efficacité des traitements anticancéreux."
}
},
{
"@type": "Question",
"name": "Les complications liées aux CDR peuvent-elles être traitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements ciblés peuvent gérer les complications associées aux CDR."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de complications lors de thérapies ciblant les CDR ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des réactions immunitaires indésirables et des effets secondaires graves."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de maladies liées aux CDR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme la génétique, l'environnement et le mode de vie augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque lié aux CDR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des CDR et augmenter le risque de maladies."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les CDR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut altérer la réponse immunitaire et affecter les CDR."
}
},
{
"@type": "Question",
"name": "Les infections antérieures influencent-elles les CDR ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections passées peuvent modifier la structure et la fonction des CDR."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie affecte-t-il les CDR ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut améliorer la fonction des CDR et réduire le risque de maladies."
}
}
]
}
]
}
Network meta-analysis has been an essential methodology of systematic reviews for comparative effectiveness research. The restricted maximum likelihood (REML) method is one of the current standard inf...
With recent advancements in bronchoscopic procedures, data on the best modality to sample peripheral pulmonary lesions (PPLs) is lacking, especially comparing bronchoscopy with computed tomography-gui...
We performed a meta-analysis, pairwise meta-analysis and network meta-analysis on studies reporting diagnostic yield and complications with the use of CT-TBNA, radial endobronchial ultrasound (rEBUS),...
We included 363 studies. The overall pooled diagnostic yield was 78.1%, the highest with CT-TBNA (88.9%), followed by RAB (84.8%) and the least with rEBUS (72%). In the pairwise meta-analysis, only rE...
Although CT-TBNA is the most effective approach to sample PPLs, RAB has a comparable diagnostic yield with a lesser complication rate. Further prospective studies are needed comparing CT-TBNA and RAB....
Eczema (atopic dermatitis) is the most burdensome skin condition worldwide and cannot currently be prevented or cured. Topical anti-inflammatory treatments are used to control eczema symptoms, but the...
To compare and rank the efficacy and safety of topical anti-inflammatory treatments for people with eczema using a network meta-analysis....
We searched the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase and trial registries on 29 June 2023, and checked the reference lists of included studies....
We included within-participant or between-participant randomised controlled trials (RCTs) in people of any age with eczema of any severity, but excluded trials in clinically infected eczema, seborrhoe...
We used standard Cochrane methods. Primary outcomes were patient-reported eczema symptoms, clinician-reported eczema signs and investigator global assessment. Secondary outcomes were health-related qu...
We included 291 studies involving 45,846 participants with the full spectrum of eczema severity, mainly conducted in high-income countries in secondary care settings. Most studies included adults, wit...
Potent TCS, JAK inhibitors and tacrolimus 0.1% were consistently ranked as amongst the most effective topical anti-inflammatory treatments for eczema and PDE-4 inhibitors as amongst the least effectiv...
Despite considerable improvement in outcomes for preterm infants, rates of bronchopulmonary dysplasia (BPD) remain high, affecting an estimated 33% of very low birthweight infants, with corresponding ...
To determine whether differences in efficacy and safety exist between high-dose dexamethasone, moderate-dose dexamethasone, low-dose dexamethasone, hydrocortisone, and placebo in the prevention of BPD...
We searched the Cochrane Library for all systematic reviews of systemic corticosteroids for the prevention of BPD and searched for completed and ongoing studies in the following databases in January 2...
We included randomized controlled trials (RCTs) in preterm infants (< 37 weeks' gestation) at risk for BPD that evaluated systemic corticosteroids (high-dose [≥ 4 mg/kg cumulative dose] dexamethasone,...
Our main information sources were the systematic reviews, with reference to the original manuscript only for data not included in these reviews. Teams of two paired review authors independently perfor...
We included 59 studies, involving 6441 infants, in our analyses. Only six of the included studies provided direct comparisons between any of the treatment (dexamethasone or hydrocortisone) groups, for...
Low-dose dexamethasone increased the risk for cerebral palsy (RR 1.92, 95% CI 1.12 to 3.28; moderate-certainty evidence) compared with control. Hydrocortisone may decrease the risk of major neurosenso...
No effect was observed for the outcomes of major neurosensory disability or cerebral palsy. The evidence for the primary outcomes was of overall low certainty, with notable deductions for imprecision ...
While early treatment with moderate-dose dexamethasone or late treatment with high-dose dexamethasone may lead to the best effects for survival without BPD, the certainty of the evidence is low. There...
Severely calcified coronary stenoses are difficult to treat with percutaneous coronary interventions. The presence of severe calcifications complicates lesion preparation, advancement of stents and ac...
We will conduct a systematic review of randomised trials enrolling patients with calcified coronary artery disease undergoing percutaneous coronary intervention. We will investigate any percutaneous t...
No ethics approval is required for this study. The results will be published in a peer-reviewed journal in this field....
CRD42021226034....
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects mainly young adults (two to three times more frequently in women than in men) and causes significant disability ...
To compare adverse effects of immunotherapies for people with MS or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects through networ...
We searched CENTRAL, PubMed, Embase, two other databases and trials registers up to March 2022, together with reference checking and citation searching to identify additional studies....
We included participants 18 years of age or older with a diagnosis of MS or CIS, according to any accepted diagnostic criteria, who were included in randomized controlled trials (RCTs) that examined o...
We used standard Cochrane methods for data extraction and pairwise meta-analyses. For NMAs, we used the netmeta suite of commands in R to fit random-effects NMAs assuming a common between-study varian...
This NMA included 123 trials with 57,682 participants...
We found mostly low and very low-certainty evidence that drugs used to treat MS may not increase SAEs, but may increase withdrawals compared with placebo. The results suggest that there is no importan...
A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM),...
We searched PubMed, Embase, Cochrane, and ClinicalTrials.gov for randomized controlled trials up to March 28, 2023. Network meta-analysis using a random-effects model was conducted to calculate risk r...
A total of fourteen trials with 75,334 patients were analyzed. Among these, 40,956 had taken SGLT2 inhibitors and 34,378 had not. One of the main results with particular findings was empagliflozin use...
Our network meta-analysis revealed that empagliflozin users with diabetes experienced a lower risk of dying from any cause than those using dapagliflozin. Additionally, canagliflozin users demonstrate...
PROSPERO [CRD42022361906]....
Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all int...
Surgical treatment of complete rectal prolapse can be undertaken via an abdominal or a perineal approach. The present network meta-analysis aimed to compare the outcomes of different abdominal and per...
A PRISMA-compliant systematic review of PubMed, Scopus, and Web of Science was conducted. Randomized clinical trials comparing two or more procedures for the treatment of complete rectal prolapse were...
Nine randomized controlled trials with 728 patients were included. The follow-up ranged between 12 and 47 months. Posterior mesh rectopexy had significantly lower odds of recurrence than did the Altem...
Posterior mesh rectopexy ranked best with the lowest recurrence while perineal procedures ranked worst with the highest recurrence rates....
Several vaccines showed a good safety profile and significant efficacy against COVID-19. Moreover, in the absence of direct head to head comparison between COVID-19 vaccines, a network meta-analysis t...
Databases PubMed, CENTRAL, medRxiv, and clinicaltrials.gov were searched. Studies were included if they were placebo-controlled clinical trials and reported the safety profile and/or effectiveness of ...
Forty-nine clinical trials that included 421,173 participants and assessed 28 vaccines were included in this network meta-analysis. The network meta-analysis showed that Pfizer is the most effective i...
We found that almost all of the vaccines included in this study crossed the threshold of 50% efficacy. However, some of them did not reach the previously mentioned threshold against the B.1.351 varian...
